Australia markets closed

BCAL Diagnostics Limited (BDX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0920+0.0010 (+1.10%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
Operating expenses
Research development
1,124
3,235
1,124
Selling general and administrative
2,000
2,545
2,000
Total operating expenses
4,104
7,898
4,104
Operating income or loss
-4,104
-7,898
-4,104
Total other income/expenses net
700.032
2,791
700.032
Income before tax
-3,385
-5,062
-3,385
Income tax expense
0
0
0
Income from continuing operations
-3,385
-5,062
-3,385
Net income
-3,385
-5,062
-3,385
Net income available to common shareholders
-3,385
-5,062
-3,385
Basic EPS
-0.02
-
-0.02
Diluted EPS
-0.02
-
-0.02
Basic average shares
210,903
-
204,286
Diluted average shares
210,903
-
204,286